Social Media Ideas for Glioblastoma

MYOF Identified as Novel Glioblastoma Therapeutic Target, Enabling Drug Discovery

Glioblastoma remains one of the deadliest brain cancers, notorious for its resistance to standard therapy and its ability to adapt under treatment pressure. In a new viral-style sc...

Reviews examine blood–brain barrier-conscious nanomedicines for glioblastoma treatment

Glioblastoma remains one of the most formidable challenges in modern cancer medicine. The aggressive brain tumor is the most common primary malignant brain tumor in adults, yet sta...

Gene Pathway Identified as Glioblastoma Target

The m6A reader protein IGF2BP3 stabilizes TRNAU1AP mRNA to drive protective selenoprotein synthesis, revealing a novel targeted drug vulnerability in glioblastoma.

Scientists map signaling networks driving disseminated glioblastoma cells in living brains

Glioblastoma has long been regarded as one of the most difficult cancers to understand and treat, not only because of its rapid growth but also because its cells can escape the pri...

How a doctor monitors herself for glioblastoma and the most common symptom

Many brain tumors are survivable. Then, there’s glioblastoma. The aggressive, fast-growing brain cancer seems to strike randomly, devastating people of all ages and their famili...

Glioblastoma Foundation Marks 10 Years with New Push to Accelerate Personalized Treatment

As glioblastoma continues to challenge the medical community, the Foundation unveils a new genomic testing lab, an advancing drug pipeline, and a sharper focus on accelerating pers...

Dad of Three Thought His Headaches Were Migraines. Doctors Found an Aggressive Grade 4 Brain Tumor Instead

Engin Tanak believed he was dealing with migraines. Instead, the headaches led doctors to discover a grade 4 glioblastoma that would change everything for him and his family. The 4...

Focused Ultrasound Delivers miRNA to Treat Glioblastoma

Researchers developed a novel therapeutic approach to combat glioblastoma, the deadliest primary brain cancer.

Core2Edge Model Maps Human Glioblastoma Cell Invasion in 3D

Researchers introduced Core2Edge, a human-tissue model combining patient-derived glioblastoma organoids with brain slices.

Cannabinoids Suppress Chemotherapy- and Radiation-Induced Death in Glioblastoma Cells

Glioblastoma is among the most aggressive and difficult-to-treat brain cancers, and a new study is drawing attention to an unexpected complication involving cannabinoids. Research...

Laser therapy offers new weapon against deadly brain cancer

"Our goal is to both extend the survival of our brain tumor patients and improve the quality of their lives."

New Strategy Shows Promise Against the Deadliest Brain Cancer

Focused ultrasound helped deliver microRNAs that targeted multiple glioblastoma genes and improved outcomes in animal models. A treatment aimed at glioblastoma must first cross one...

Researchers Discover a Potential Weak Spot in One of the Deadliest Brain Cancers

Targeting SET may make glioblastoma more responsive to radiation and chemotherapy. Glioblastoma can survive attacks that destroy many other cancer cells, helping make it one of the...

Study Compares Contrast-Enhanced Glioblastoma Resection Using Sodium Fluorescein, 5-ALA in 1,389 Patients

A 1,389-Patient Study Challenges Assumptions About Fluorescent Dyes in Glioblastoma Surgery For surgeons operating on glioblastoma, the boundary between malignant tissue and functi...

How Cellular Senescence and Immunity Drive Cancer, With Insights for Glioblastoma

Cancer biology is increasingly revealing that tumors are not defined solely by rapidly dividing malignant cells. They are dynamic ecosystems in which cancer cells, immune cells, bl...

New discovery could revolutionise treatment for deadly brain cancer

A “Double Punch” Nanoparticle Could Reveal and Destroy Brain Cancer Cells

Light-activated nanoparticles could help surgeons see glioblastoma more clearly and destroy cancer cells that remain after surgery. Glioblastoma can spread microscopic cancer cells...

How mutation disrupts cell development, driving region-specific brain tumors

Scientists at St. Jude Children's Research Hospital have shown that specific brain cells respond differently to H3.3 K27M, a mutation in the histone H3.3 protein that drives many c...

New Prediction Model Forecasts High-Grade Glioma Progression Using Radiomics and Pathomics

For patients diagnosed with high-grade gliomas, the most aggressive form of primary brain cancer, one of the most urgent clinical questions is deceptively simple: who will progress...

How Glioma Brain Cancer Hijacks Your Own Neurons to Grow

A 2026 Nature Neuroscience study reveals how glioma brain cancer hijacks the NLGN3-CSPG4-PIEZO1 pathway to exploit neuronal activity for tumor The post How Glioma Brain Cancer Hija...

α-Synuclein curbs glioma growth via CDH13–JNK/c-Jun signaling pathway

In a finding that could reshape how scientists think about one of medicine’s most stubborn brain cancers, researchers in China have discovered that α-synuclein—the protein most fam...